Cryopyrin: In from the Cold  by Lich, John D. et al.
Previews
241Immunity 24, March 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.03.004Cryopyrin: In from the Cold
Mutations in CIAS1/cryopyrin are linked to several
autoinflammatory diseases. In this issue of Immunity,
Sutterwala et al. (2006) uncover a critical role for cryo-
pyrin in the caspase-1/IL-1b axis and reveal a broader
role for cryopyrin than anticipated.
IL-1b is a potent proinflammatory cytokine that is trans-
lated as a leaderless 35 kDa precursor protein that must
be processed into its active form. The processing of
pro-IL-1b is mediated predominantly by the IL-1b con-
verting enzyme caspase-1. Treatment of macrophages
with LPS results in the production of high levels of
pro-IL-1b that accumulate in secretory lysosomal struc-
tures (Andrei et al., 2004). Yet, the release of mature
IL-1b is very inefficient in the absence of a second sig-
nal. This second signal can be provided by ATP, which
activates the ion-gated channel P2X7. This triggers the
rapid activation of caspase-1 and subsequent process-
ing and release of bioactive IL-1b (Dinarello, 2005).
Cryopyrin/PYPAF1/NALP3 is encoded by the CIAS1
gene, a member of the CATERPILLER/NOD-LRR/NLR
family of genes (Ting and Davis, 2004). Hoffman et al.
first identified point mutations within exon 3 of CIAS1
that segregate with MWS and FCAS (Hoffman et al.,
2001). However, until recently, the role of cryopyrin in
these disorders has remained elusive. Sutterwala et al.
found that when prestimulated with LPS, wild-type (wt)
macrophages activated caspase-1 and released large
quantities of IL-1b upon ATP stimulation, whereas mac-
rophages from CIAS12/2 mice did not (Sutterwala et al.,
2006). This indicates that cryopyrin is a key factor in
caspase-1 activation and IL-1b secretion after ATP stim-
ulation. Cryopyrin displayed a level of specificity, as it
was not required for caspase-1 activation and IL-1b
release in response to Salmonella typhimurium. A previ-
ous report has demonstrated that IPAF, another mem-
ber of the family, is required for IL-1b release in re-
sponse to this bacterium (Mariathasan et al., 2004).
These findings suggest that distinct CATERPILLER
family members respond to different stimuli.
The ability of cryopyrin to promote IL-1bmaturation re-
quires its interaction with a large multiprotein complex
termed the inflammasome (Martinon et al., 2002). In addi-
tion to cryopyrin, this molecular ‘‘platform’’ includes the
core components ASC and caspase-1. In the absence
of either of these core components, pro-IL-1b is not pro-
cessed into its active form (Martinon et al., 2002). Ac-
cordingly, Sutterwala et al. demonstrated that ASC2/2
mice were resistant to lethal doses of LPS (Sutterwala
et al., 2006). This correlated with significantly reduced
levels of serum IL-1b, supporting the important role of
ASC in IL-1b secretion. In contrast, the results from
CIAS12/2 mice were less straightforward. At lethal dos-
esofLPS,CIAS12/2micesuccumbedtoendotoxicshock
at rates comparable to wt mice. However, CIAS12/2
mice exhibited enhanced survival when challenged withsublethal doses of LPS, suggesting that cryopyrin serves
a limited role in endotoxic shock. Even though CIAS12/2
mice did not survive lethal doses of LPS, serum IL-1b
in these mice remained as low as IL-1b levels observed
in ASC2/2 mice. This raises the strong possibility that
ASC plays a more complex role in inflammatory mecha-
nisms besides regulating IL-1b maturation.
A common feature ofCIAS1-associated diseases is re-
current skin manifestations, which are alleviated by IL-1b
neutralizing therapies. To determine the role of cryopyrin
in cutaneous inflammation, Sutterwala et al. (2006)
turned to a murine model of contact-mediated hypersen-
sitivity. This adaptive immune response consists of two
phases. In the sensitization phase, T cells are primed to
respond to haptens applied to the skin. In the second
or elicitation phase, the hapten is reapplied to the skin,
resulting in a localized inflammatory response. Sutter-
wala et al. sensitized wt and CIAS12/2 mice with the
hapten trinitrophenylchloride (TNP-CL) by applying it to
the abdomen. The mice later were challenged by apply-
ing TNP-CL to the ear. Wt mice developed ear swelling
within 24 hr of the second challenge, whereas CIAS12/2
mice displayed significantly less ear swelling. To deter-
mine which phase of the response cryopyrin regulated,
the authors transferred immune cells from sensitized
wt mice into unsensitized wt or CIAS12/2 mice. Both wt
andCIAS12/2mice developed ear swelling by 24 hr, sug-
gesting that cryopyrin is required for the sensitization
phase, but not the elicitation phase. These results also
implicate cryopyrin in the priming of T cells and link cry-
opyrin to the development of adaptive immunity.
The report by Sutterwala et al. supports a paper by
Mariathasan et al., which also demonstrates that cryo-
pyrin is required for ATP-triggered release of IL-1b
from LPS-stimulated macrophages (Mariathasan et al.,
2006). ATP induces a rapid efflux of cytoplasmic K+,
and the authors demonstrate a critical role for this in
the activation of the cryopyrin inflammasome. In addi-
tion, these authors also found that cryopyrin is required
for IL-1b secretion in response to the Gram-positive
bacteria Staphylococcus aureus and Listeria monocyto-
genes, but not to the Gram-negative Salmonella typhi-
murium or Francisella tularensis.
In addition to responding to ATP, K+ depletion, and
bacteria, two other reports suggest cryopyrin may func-
tion in additional pathways leading to IL-1b release.
Kanneganti et al. determined that cryopyrin is required
for IL-1b maturation in response to R848 (TLR7/8 ago-
nist), R837 (TLR7 agonist), and bacterial mRNA (TLR7/8
agonist) (Kanneganti et al., 2006). Interestingly, these
agonists induce cryopyrin-dependent IL-1b maturation
in the absence of TLR signaling. This raises the pos-
sibility that cryopyrin ‘‘senses’’ these agonists within
the cytoplasm in a manner analogous to the recognition
of muramyl dipeptide (MDP) by NOD2. Alternatively,
because R848 and R837 are purine analogs, it is also
possible that these compounds stimulate members of
the P2X or P2Y family of purine receptors, similar to
ATP stimulation. In contrast to Sutterwala et al. and
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242Figure 1. Cryopyrin Is a Key Component of IL-1b Maturation in Response to Different Stimuli
LPS treatment of macrophages induces the expression of pro-IL-1b that accumulates in secretory lysosomal vesicles (secLys). ATP stimulation
of the purine receptor P2X7 leads to rapid efflux of K+. This activates phospholipases such as calcium-independent phospholipase A2 (iPLA2).
iPLA2 induces the colocalization of caspase-1 with pro-IL-1b within secretory lysosomes. The precise mechanism by which ATP and other
agonists (boxes) induce the assembly/activation of the cryopyrin inflammasome is not known. The inflammasome consists of cryopyrin and
the core components ASC and caspase-1. These proteins assemble via homotypic interactions between their respective pyrin (PyD) and CARD
domain. In humans, the adaptor protein CARDINAL is thought to interact with the nucleotide binding domain (NBD) of cryopyrin via its FIIND
domain. CARDINAL also binds caspase-1 via CARD-CARD interactions. At present, a CARDINAL homolog has not been identified in mice.
The activation of caspase-1 is thought to occur due to the induced proximity of multiple caspase-1 molecules within the inflammasome. In ad-
dition to ATP, other stimuli activate the cryopyrin pathway. These include Gram-positive bacteria, R837/R848, bacterial RNA, gout-associated
crystals, nigericin, and maitotoxin.Mariathasan et al., however, this report did not detect
a role for ATP in cryopyrin-mediated IL-1b release.
In a final report, Martinon et al. determined that cryo-
pyrin is required for IL-1b secretion in response to
monosodium urate or calcium pyrophosphate dehy-
drate crystals, the deposition of which leads to gout
(Martinon et al., 2006). In this case, IL-1b maturation oc-
curred in the presence of a P2X7 inhibitor, suggesting
cryopyrin responds to signals other than those initiated
from this ATP receptor. IL-1b processing and secretion
was blocked by the microtubule inhibitor colchicine,
suggesting that cytoskeletal events, such as endocyto-
sis or vesicle trafficking, are required for cryopyrin-
mediated IL-1b release. Interestingly, colchicine is also
an accepted clinical treatment for gout.
The reports by Mariathasan et al. and Sutterwala et al.
indicate a role for cryopyrin in caspase-1 activation and
IL-1b maturation in response to ATP (Mariathasan et al.,
2006; Sutterwala et al., 2006). Although the mechanism
by which cryopyrin performs this function remains
unclear, studies focusing on ATP-mediated caspase-1
activation and IL-1b release may offer some clues.
Extracellular ATP binds the cell surface receptor P2X7and induces the rapid efflux of K+ (Figure 1). The deple-
tion of K+ leads to the activation of calcium-independent
phospholipase A2 (iPLA2) (Andrei et al., 2004). iPLA2
induces the colocalization of caspase-1 and pro-IL-1b
within secretory lysosomes (Andrei et al., 2004); pre-
sumably, this leads to caspase-1 activation and pro-
cessing of pro-IL-1b. Perhaps this iPLA2-mediated
mechanism also permits vesicular import of the cryo-
pyrin inflammasome, thus allowing it to colocalize with
caspase-1 and pro-IL-1b. This supports the observation
that inflammasome components are released from
stimulated macrophages along with IL-1b. Interestingly,
iPLA2 activity also leads to the production of cytoplas-
mic lipids such as lysophospholipids and arachidonic
acid. This has prompted the suggestion that cryopyrin
may respond to lipid second messengers generated
by phospholipase activity (Andrei et al., 2004).
In conclusion, the four recent papers describing
CIAS12/2 mice reveal a broad role for cryopyrin in
caspase-1 activation and IL-1b maturation. Signals
that require cryopyrin include ATP, K+ efflux, two
Gram-positive bacteria, the purine analogs R848 and
R837, bacterial mRNA, and gout-associated crystals
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243(Kanneganti et al., 2006; Mariathasan et al., 2006; Marti-
non et al., 2006; Sutterwala et al., 2006). In addition to
these activators of innate immunity, a function for cryo-
pyrin in priming the adaptive immune system is shown.
In contrast, cryopyrin is not required for IL-1b secretion
in response to two Gram-negative bacteria (Mariathasan
et al., 2006; Sutterwala et al., 2006), MDP, or purified ag-
onists of TLR2, TLR4, TLR6, and TLR7 (Kanneganti et al.,
2006). Thus, cryopyrin participates in immune response
to specific stimuli. It is tantalizing to speculate that other
CATERPILLER proteins also demonstrate specificity.
Indeed, this is the case for Salmonella typhimurium that
requires IPAF and MDP that requires NOD2. The devel-
opment of mice deficient in additional CATERPILLER
genes will help resolve this important question.
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Rewiring Phagocytic
Signal Transduction
In this issue of Immunity, Hall et al. (2006) have exam-
ined primary macrophages from Vav12/2/Vav32/2 and
Rac12/2/Rac22/2mice to produce a new picture of Fcg
receptor and complement receptor 3 intracellular
signaling.
Many studies of phagocytic signaling mechanisms have
relied on the reductionist approach of examining indi-
vidual receptors in transfected fibroblasts or model leu-
kocyte cell lines (Underhill and Ozinsky, 2002). This pro-
cess has been extensively used to study FcgRs and
complement receptors (mainly CR3, also known as in-
tegrin Mac-1 or aMb2), which has lead to the general
view that these receptors utilize different intracellular
signaling pathways to initiate phagocytosis (Cougoule
et al., 2004). The FcgRs bind IgG-coated particles, while
CR3 recognizes particles opsonized by activated com-
plement (mainly C3bi). Engagement of FcgRs activates
a well-described intracellular signaling pathway in
phagocytes that is highly analogous to the pathways
utilized by lymphocyte antigen receptors. This pathway
involves the sequential activation of tyrosine kinasesSelected Reading
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(first Src family members, then subsequently Syk),
which induces phosphorylation of a series of intracellu-
lar substrates, including Vav GEF proteins that in turn
activate Rho family GTPases (mainly Rac and Cdc42),
leading to localized actin polymerization beneath the
particle (Patel et al., 2002). Actin polymerization below
the FcgR bound particle drives membrane recruitment
and allows the phagocyte to extend filopodia around
the particle, leading to ingestion. In contrast, phago-
cytosis of complement-opsonized particles by CR3 is
tyrosine kinase independent and is thought to depend
mainly on Rho GTPase (not Rac or Cdc42) activation
(Caron and Hall, 1998). The GEFs responsible for acti-
vating Rho during CR3-mediated phagocytosis are un-
known. Although localized actin polymerization is a
feature of CR3-mediated phagocytosis, uptake via
these receptors does not involve filopodial extensions
around the particle—instead, complement-opsonized
particles tend to sink into the phagocyte (Aderem and
Underhill, 1999). These dramatic differences in intra-
cellular signaling pathways have been used as explana-
tions for why FcgR phagocytosis tends to be more
proinflammatory (i.e., result in higher oxidase activa-
tion and greater cytokine release) than CR3-mediated
phagocytosis.
Numerous studies have validated these basic obser-
vations, which were made mainly in macrophage and
